Asiatic Acid, a Natural Compound that Exerts Beneficial Effects on the Cystometric and Biochemical Parameters in the Retinyl Acetate-Induced Model of Detrusor Overactivity

Scientists have been constantly looking for new synthetic and natural compounds that could have beneficial effects in bladder overactivity. Our attention was drawn by asiatic acid that influences a number of molecules and signaling pathways relevant for the proper functioning of the urinary tracts in humans. In the present project we wanted to check whether asiatic acid would have positive effects in the confirmed animal model of detrusor overactivity (DO) and whether it would affect the bladder blood flow, urothelium thickness, inflammatory and oxidative stress markers, neurotrophic and growth factors, and other parameters important for the activity of the urinary bladder. The outcomes of our study showed that a 14-day administration of asiatic acid (30 mg/kg/day) by oral gavage normalizes the cystometric parameters corresponding to DO and reduces the accompanying oxidative stress (measured by the levels of malondialdehyde–61,344 ± 24,908 pg/ml vs. 33,668 ± 5,071 pg/ml, 3-nitrotyrosine–64,615 ± 25,433 pg/ml vs. 6,563 ± 1,736 pg/ml, and NOS2–2,506 ± 411.7 vs. 3,824 ± 470.1 pg/ml). Moreover, it decreases the urinary secretion of neurotrophins (BDNF–304.4 ± 33.21 pg/ml vs. 119.3 ± 11.49 pg/ml and NGF–205.5 ± 18.50 vs. 109.7 ± 15.94 pg/ml) and prevents the changes in a range of biomarkers indicating the dysfunction of the urinary bladder, CGRP (421.1 ± 56.64 vs. 108.1 ± 11.73 pg/ml), E-Cadherin (773.5 ± 177.5 pg/ml vs. 1,560 ± 154.5 pg/ml), OCT3 (3,943 ± 814.6 vs. 1,018 ± 97.07 pg/ml), SNAP-23 (6,763 ± 808.9 pg/ml vs. 3,455 ± 554.5 pg/ml), SNAP-25 (2,038 ± 162.7 pg/ml vs. 833.3 ± 65.48), substance P (171.7 ± 16.86 pg/ml vs. 65.07 ± 8.250 pg/ml), SV2A (1,927 ± 175.3 pg/ml vs. 1,154 ± 254.9 pg/ml), tight junction protein 1 (360.1 ± 95.05 pg/ml vs. 563.4 ± 65.43 pg/ml), VAChT (16,470 ± 2,419 pg/ml vs. 7,072 ± 1,339 pg/ml), VEGFA (318.3 ± 37.89 pg/ml vs. 201.5 ± 22.91 pg/ml). The mentioned parameters are associated with smooth muscle contractions, urothelial barrier, transportation and release of transmitters, or bladder compensation. Thus, the presented findings allow to suggest a possible future role of asiatic acid in the prevention of conditions accompanied by DO, such as overactive bladder.

[1]  A. Wróbel,et al.  Stimulation of atypical cannabinoid receptor GPR55 abolishes the symptoms of detrusor overactivity in spontaneously hypertensive rats. , 2020, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[2]  A. Wein,et al.  Are oxidative stress and ischemia significant causes of bladder damage leading to lower urinary tract dysfunction? Report from the ICI‐RS 2019 , 2020, Neurourology and urodynamics.

[3]  V. Uddandrao,et al.  Antiobesity efficacy of asiatic acid: down-regulation of adipogenic and inflammatory processes in high fat diet induced obese rats , 2020, Archives of physiology and biochemistry.

[4]  M. T. Islam,et al.  Anti-Cancer Effects of Asiatic Acid, A Triterpene From Centilla Asiatica L: A Literature Review. , 2019, Anti-cancer agents in medicinal chemistry.

[5]  L. Cui,et al.  Asiatic Acid Attenuates Bone Loss by Regulating Osteoclastic Differentiation , 2019, Calcified Tissue International.

[6]  F. Cruz,et al.  Urinary Biomarkers in Overactive Bladder: Revisiting the Evidence in 2019. , 2019, European urology focus.

[7]  G. Keri̇moğlu,et al.  Uroprotective effect of ambroxol in cyclophosphamide-induced cystitis in mice , 2019, International Urology and Nephrology.

[8]  S. Bae,et al.  Effects of a combination of herbal extracts (modified Ojayeonjonghwan (Wuzi Yanzong wan)) on partial urethral obstruction-induced detrusor overactivity in rats: impact on the nitric oxide pathway and oxidative stress , 2019, BMC Complementary and Alternative Medicine.

[9]  J. Dudka,et al.  Blebbistatin reveals beneficial effects on the cystometric parameters in an animal model of detrusor overactivity , 2019, Naunyn-Schmiedeberg's Archives of Pharmacology.

[10]  M. Tantisira,et al.  Safety and Pharmacokinetics of Standardized Extract of Centella asiatica (ECa 233) Capsules in Healthy Thai Volunteers: A Phase 1 Clinical Study , 2019, Planta Medica.

[11]  T. Manivasagam,et al.  Asiatic Acid Attenuated Aluminum Chloride-Induced Tau Pathology, Oxidative Stress and Apoptosis Via AKT/GSK-3β Signaling Pathway in Wistar Rats , 2019, Neurotoxicity Research.

[12]  A. Bishayee,et al.  Pentacyclic triterpenes: New tools to fight metabolic syndrome. , 2018, Phytomedicine : international journal of phytotherapy and phytopharmacology.

[13]  J. Dudka,et al.  Inhibition of Rho kinase by GSK 269962 reverses both corticosterone‐induced detrusor overactivity and depression‐like behaviour in rats , 2018, European journal of pharmacology.

[14]  Chandragouda R. Patil,et al.  Pharmacological Properties, Molecular Mechanisms, and Pharmaceutical Development of Asiatic Acid: A Pentacyclic Triterpenoid of Therapeutic Promise , 2018, Front. Pharmacol..

[15]  Huaxi Xu,et al.  Asiatic Acid Prevents Oxidative Stress and Apoptosis by Inhibiting the Translocation of α-Synuclein Into Mitochondria , 2018, Front. Neurosci..

[16]  J. Lou,et al.  Centella asiatica triterpenes for diabetic neuropathy: a randomized, double-blind, placebo-controlled, pilot clinical study. , 2018, Esperienze dermatologiche.

[17]  M. Yin,et al.  Asiatic acid and maslinic acid attenuated kainic acid-induced seizure through decreasing hippocampal inflammatory and oxidative stress , 2018, Epilepsy Research.

[18]  Xianting Ding,et al.  Pharmacological Review on Asiatic Acid and Its Derivatives: A Potential Compound , 2018, SLAS technology.

[19]  A. Weintraub,et al.  Overactive Bladder Syndrome: Evaluation and Management , 2018, Current Urology.

[20]  C. Kaya,et al.  A comparison of normal and high post-void residual urine and urodynamic parameters in women with overactive bladder , 2017, Turkish journal of obstetrics and gynecology.

[21]  Xiaoning He,et al.  Treatment of obesity-associated overactive bladder by the phosphodiesterase type-4 inhibitor roflumilast , 2017, International Urology and Nephrology.

[22]  R. Franzen,et al.  Puzzling Out Synaptic Vesicle 2 Family Members Functions , 2017, Front. Mol. Neurosci..

[23]  F. Wei,et al.  Asiatic acid ameliorates pulmonary fibrosis induced by bleomycin (BLM) via suppressing pro-fibrotic and inflammatory signaling pathways. , 2017, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[24]  Xuming Deng,et al.  Asiatic acid enhances Nrf2 signaling to protect HepG2 cells from oxidative damage through Akt and ERK activation. , 2017, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[25]  Demin Zhou,et al.  Selective oxidation-reduction and esterification of asiatic acid by Pestalotiopsis microspora and anti-HCV activity , 2017 .

[26]  J. Dudka,et al.  Rho kinase inhibition ameliorates cyclophosphamide-induced cystitis in rats , 2017, Naunyn-Schmiedeberg's Archives of Pharmacology.

[27]  T. Rechberger,et al.  The influence of Rho‐kinase inhibition on acetic acid‐induced detrusor overactivity , 2017, Neurourology and urodynamics.

[28]  Wu Jiang,et al.  Neuroprotective effect of asiatic acid against spinal cord injury in rats. , 2016, Life sciences.

[29]  S. Radomski,et al.  Review of the epidemiology of overactive bladder. , 2016, Research and reports in urology.

[30]  T. Rechberger,et al.  Fourteen-day administration of corticosterone may induce detrusor overactivity symptoms , 2016, International Urogynecology Journal.

[31]  C-H Chang,et al.  Effect of detrusor botulinum toxin a injection on urothelial dysfunction in patients with chronic spinal cord injury: a clinical and immunohistochemistry study before and after treatment , 2016, Spinal Cord.

[32]  M. Mong,et al.  Antibacterial effects and action modes of asiatic acid. , 2015, BioMedicine.

[33]  T. Rechberger,et al.  A new model of detrusor overactivity in conscious rats induced by retinyl acetate instillation. , 2015, Journal of pharmacological and toxicological methods.

[34]  Eric J. Gonzalez,et al.  The Effects of Tempol on Cyclophosphamide-Induced Oxidative Stress in Rat Micturition Reflexes , 2015, TheScientificWorldJournal.

[35]  A. Kanai,et al.  Effect of botulinum toxin A on urothelial‐release of ATP and expression of SNARE targets within the urothelium , 2015, Neurourology and urodynamics.

[36]  Jane-Dar Lee,et al.  Decreased expression of zonula occludens-1 and occludin in the bladder urothelium of patients with interstitial cystitis/painful bladder syndrome. , 2014, Journal of the Formosan Medical Association = Taiwan yi zhi.

[37]  H. Kuo,et al.  Down regulation of vascular endothelial growth factor is associated with decreased inflammation after intravesical OnabotulinumtoxinA injections combined with hydrodistention for patients with interstitial cystitis--clinical results and immunohistochemistry analysis. , 2013, Urology.

[38]  E. Walters,et al.  Retinoids activate the irritant receptor TRPV1 and produce sensory hypersensitivity. , 2013, The Journal of clinical investigation.

[39]  V. Khullar,et al.  Biomarkers in overactive bladder , 2013, International Urogynecology Journal.

[40]  Q. Lei,et al.  VEGF induces sensory and motor peripheral plasticity, alters bladder function, and promotes visceral sensitivity , 2012, BMC Physiology.

[41]  Sung-Ho Chen,et al.  Differences in mast cell infiltration, E-cadherin, and zonula occludens-1 expression between patients with overactive bladder and interstitial cystitis/bladder pain syndrome. , 2012, Urology.

[42]  S. Oger,et al.  Minimal effective dose of dysport and botox in a rat model of neurogenic detrusor overactivity. , 2012, European urology.

[43]  L. Cardozo,et al.  Overactive bladder: diagnosis and management. , 2012, Maturitas.

[44]  F. Cruz,et al.  Neurotrophins in the Lower Urinary Tract: Becoming of Age , 2011, Current neuropharmacology.

[45]  K. Andersson,et al.  Rodent models for urodynamic investigation , 2011, Neurourology and urodynamics.

[46]  A. Wein,et al.  Acute colonic inflammation triggers detrusor instability via activation of TRPV1 receptors in a rat model of pelvic organ cross-sensitization. , 2011, American journal of physiology. Regulatory, integrative and comparative physiology.

[47]  F. Cruz,et al.  Biomarkers in Overactive Bladder: A New Objective and Noninvasive Tool? , 2011, Advances in urology.

[48]  K. Coyne,et al.  Persistence and adherence in the treatment of overactive bladder syndrome with anticholinergic therapy: a systematic review of the literature , 2011, International journal of clinical practice.

[49]  J. Kaleczyc,et al.  The influence of botulinum toxin type A (BTX) on the immunohistochemical characteristics of noradrenergic and cholinergic nerve fibers supplying the porcine urinary bladder wall. , 2011, Polish journal of veterinary sciences.

[50]  O. B. Hani,et al.  Urodynamic Detrusor Overactivity in Patients with Overactive Bladder Symptoms , 2011, International neurourology journal.

[51]  M. Drake,et al.  Animal models in overactive bladder research. , 2011, Handbook of experimental pharmacology.

[52]  K. Andersson Detrusor myocyte activity and afferent signaling , 2010, Neurourology and urodynamics.

[53]  Luyong Zhang,et al.  Synthesis and Biological Evaluation of Asiatic Acid Derivatives as Inhibitors of Glycogen Phosphorylases , 2009, Chemistry & biodiversity.

[54]  C. Harding,et al.  Is low bladder compliance predictive of detrusor overactivity? , 2009, Neurourology and urodynamics.

[55]  R. Dipasquale Effective Use of Herbal Medicine in Urinary Tract Infections , 2008, Journal of dietary supplements.

[56]  Y. Yoshimura,et al.  The effects of ovariectomy and estrogen replacement on acetylcholine release from nerve fibres and passive stretch‐induced acetylcholine release in female rat bladder , 2007, Neurourology and urodynamics.

[57]  H. Koepsell,et al.  Acetylcholine and molecular components of its synthesis and release machinery in the urothelium. , 2007, European urology.

[58]  W. Schaefer Re: Is the bladder a reliable witness for predicting detrusor overactivity? H. Hashim and P. Abrams. J Urol, 175: 191-195, 2006. , 2006, The Journal of urology.

[59]  D. Rapp,et al.  Botulinum toxin type a inhibits calcitonin gene-related peptide release from isolated rat bladder. , 2006, The Journal of urology.

[60]  A. Wein,et al.  Overactive bladder: a better understanding of pathophysiology, diagnosis and management. , 2006, The Journal of urology.

[61]  A. Brading Spontaneous activity of lower urinary tract smooth muscles: correlation between ion channels and tissue function , 2006, The Journal of physiology.

[62]  R. Levin,et al.  Effects of castration on female rabbit bladder physiology and morphology. , 2004, Urology.

[63]  R. Saito,et al.  Possible mechanisms inducing glomerulations in interstitial cystitis: relationship between endoscopic findings and expression of angiogenic growth factors. , 2004, The Journal of urology.

[64]  L. Cardozo,et al.  The role of estrogens in female lower urinary tract dysfunction. , 2003, Urology.

[65]  M. Fall,et al.  The standardisation of terminology of lower urinary tract function: report from the Standardisation Sub-committee of the International Continence Society. , 2002 .

[66]  C. Dubeau,et al.  Quest for a detrusor overactivity index. , 2002, The Journal of urology.

[67]  G. Belcaro,et al.  Treatment of Diabetic Microangiopathy and Edema with Total Triterpenic Fraction of Centella asiatica: A Prospective, Placebo-Controlled Randomized Study , 2001, Angiology.

[68]  MJ Drake,et al.  Model of peripheral autonomous modules and a myovesical plexus in normal and overactive bladder function , 2001, The Lancet.

[69]  M. Damaser,et al.  Effects of anesthesia on cystometry and leak point pressure of the female rat. , 2001, Life sciences.

[70]  W. C. Groat A neurologic basis for the overactive bladder , 1997 .

[71]  K. Moore,et al.  Distribution and colocalization of calcitonin gene-related peptide, tachykinins, and vasoactive intestinal peptide in normal and idiopathic unstable human urinary bladder. , 1997, Laboratory investigation; a journal of technical methods and pathology.